Appropriate use of Mohs micrographic surgery in immunocompromised patients is high, and published indications for Mohs decrease inappropriate use.

MLA

Shin, Thuzar M., et al. “Appropriate Use of Mohs Micrographic Surgery in Immunocompromised Patients Is High, and Published Indications for Mohs Decrease Inappropriate Use.” Journal of the American Academy of Dermatology, vol. 85, no. 2, Aug. 2021, pp. 514–16. EBSCOhost, https://doi.org/10.1016/j.jaad.2018.12.050.

APA

Shin, T. M., O’Malley, V., Tuttle, S., Howe, N., Etzkorn, J. R., Sobanko, J. F., Margolis, D. J., & Miller, C. J. (2021). Appropriate use of Mohs micrographic surgery in immunocompromised patients is high, and published indications for Mohs decrease inappropriate use. Journal of the American Academy of Dermatology, 85(2), 514–516. https://doi.org/10.1016/j.jaad.2018.12.050

Chicago

Shin, Thuzar M, Victoria O’Malley, Scott Tuttle, Nicole Howe, Jeremy R Etzkorn, Joseph F Sobanko, David J Margolis, and Christopher J Miller. 2021. “Appropriate Use of Mohs Micrographic Surgery in Immunocompromised Patients Is High, and Published Indications for Mohs Decrease Inappropriate Use.” Journal of the American Academy of Dermatology 85 (2): 514–16. doi:10.1016/j.jaad.2018.12.050.